Literature DB >> 3713965

Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition.

J H McDonough, R F Smith, C D Smith.   

Abstract

Rats (N = 45) pretrained to lever press for milk reinforcement on a continuous reinforcement (CRF) schedule were injected with 100-110 micrograms/kg of the anticholinesterase soman (N = 24) or saline (N = 21) SC. Subjects exposed to soman experienced moderate to severe acute symptoms of anticholinesterase intoxication. After a 3 week recovery period, all surviving subjects were retrained on CRF, then given 45 training sessions on a differential reinforcement of low rates (DRL) 20 sec schedule, followed by 10 sessions of extinction. Brains of all subjects were then examined for evidence of neuropathology. Subjects exposed to soman showed no improvement over sessions in the number of reinforcements earned on the DRL schedule due to an inefficient patterning of responses. There were no differences between groups in the number of total DRL responses or terminal extinction responses. Neuropathology was most evident in dorsal thalamic areas, primary olfactory/piriform cortex and amygdala of subjects exposed to soman. There were significant correlations between the severity of acute intoxication scores, degree of neuropathology, and deficits in DRL performance. The results demonstrate that exposure to high doses of this anticholinesterase agent can result in neural damage and persistent decrements in performance of certain operant tasks.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713965

Source DB:  PubMed          Journal:  Neurobehav Toxicol Teratol        ISSN: 0275-1380


  11 in total

Review 1.  A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.

Authors:  Asheebo Rojas; Thota Ganesh; Wenyi Wang; Jennifer Wang; Raymond Dingledine
Journal:  Neurobiol Dis       Date:  2019-02-25       Impact factor: 5.996

2.  Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.

Authors:  Asheebo Rojas; Thota Ganesh; Zahra Manji; Theon O'neill; Raymond Dingledine
Journal:  Neuropharmacology       Date:  2016-07-29       Impact factor: 5.250

3.  Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.

Authors:  James P Apland; Taiza H Figueiredo; Felicia Qashu; Vassiliki Aroniadou-Anderjaska; Adriana P Souza; Maria F M Braga
Journal:  Neurotoxicology       Date:  2010-06-08       Impact factor: 4.294

Review 4.  Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review.

Authors:  Mohamed B Abou-Donia; Briana Siracuse; Natasha Gupta; Ashly Sobel Sokol
Journal:  Crit Rev Toxicol       Date:  2016-10-05       Impact factor: 5.635

5.  Alpha-Linolenic Acid-Induced Increase in Neurogenesis is a Key Factor in the Improvement in the Passive Avoidance Task After Soman Exposure.

Authors:  Tetsade C B Piermartiri; Hongna Pan; Jun Chen; John McDonough; Neil Grunberg; James P Apland; Ann M Marini
Journal:  Neuromolecular Med       Date:  2015-04-29       Impact factor: 3.843

6.  Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Felicia Qashu; Maria F M Braga
Journal:  Neurotoxicology       Date:  2009-07-08       Impact factor: 4.294

7.  Efficacy of the GluK1/AMPA receptor antagonist LY293558 against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.

Authors:  James P Apland; Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; Carol E Green; Robert Swezey; Chun Yang; Felicia Qashu; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2012-10-05       Impact factor: 4.030

8.  Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Authors:  J P Apland; V Aroniadou-Anderjaska; M F M Braga
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

9.  Characterization and treatment of spontaneous recurrent seizures following nerve agent-induced status epilepticus in mice.

Authors:  Hilary S McCarren; Margaret R Eisen; Dominique L Nguyen; Parker B Dubée; Cherish E Ardinger; Emily N Dunn; Kari M Haines; Antonia N Santoro; Paige M Bodner; Celinia A Ondeck; Cary L Honnold; John H McDonough; Phillip H Beske; Patrick M McNutt
Journal:  Epilepsy Res       Date:  2020-03-10       Impact factor: 3.045

10.  (-)-Phenserine attenuates soman-induced neuropathology.

Authors:  Jun Chen; Hongna Pan; Cynthia Chen; Wei Wu; Kevin Iskandar; Jeffrey He; Tetsade Piermartiri; David M Jacobowitz; Qian-Sheng Yu; John H McDonough; Nigel H Greig; Ann M Marini
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.